Level Biotechnology (3118) — Cash Flow Quality Index
Level Biotechnology (3118) has a Cash Flow Quality Index of 0.44x as of September 2025. Operating cash flow of NT$11.81 Million is below net income of NT$26.84 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Level Biotechnology (3118) cash conversion ratio to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Level Biotechnology Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for Level Biotechnology across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 3118 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Level Biotechnology (2017–2024)
Year-by-year earnings quality comparison for Level Biotechnology. For live market cap and the full company financial profile, see 3118 company net worth.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.99x | NT$64.10 Million | NT$64.81 Million | ▲ +10.8% |
| 2023 | 0.89x | NT$70.21 Million | NT$78.65 Million | ▲ +0.4% |
| 2022 | 0.89x | NT$65.07 Million | NT$73.16 Million | ▼ -51.6% |
| 2021 | 1.84x | NT$155.95 Million | NT$84.89 Million | ▲ +60.1% |
| 2020 | 1.15x | NT$83.23 Million | NT$72.54 Million | ▼ -50.1% |
| 2019 | 2.30x | NT$109.02 Million | NT$47.40 Million | ▲ +234.3% |
| 2018 | 0.69x | NT$26.77 Million | NT$38.91 Million | ▼ -34.1% |
| 2017 | 1.04x | NT$71.29 Million | NT$68.31 Million | — |